-+ 0.00%
-+ 0.00%
-+ 0.00%

NuWays reiterates Eckert & Ziegler buy rating, sets EUR 23 target price

PUBT·04/20/2026 07:01:23
Listen to the news
NuWays reiterates Eckert & Ziegler buy rating, sets EUR 23 target price
  • NuWays reiterated a BUY rating on Eckert & Ziegler with a 12-month target price of EUR 23.
  • Report flagged May 12 as date for Q1 2026 results, forecasting sales of EUR 72.5 million.
  • NuWays projected adjusted EBIT of EUR 16 million, implying a 22.1% margin.
  • Medical segment expected to drive growth, with Q1 segment sales seen up 13% to EUR 39 million.
  • Analyst expects no license income in Q1, with remaining Telix-related license revenue of EUR 5.6 million likely later in 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eckert & Ziegler SE published the original content used to generate this news brief via EQS News, a service of EQS Group AG (Ref. ID: rc_25454), on April 20, 2026, and is solely responsible for the information contained therein.